https://www.selleckchem.com/pr....oducts/vorapaxar.htm
To evaluate clinical implication of prediabetes, we compared a 2-year major clinical outcome including patient-oriented composite outcomes (POCOs), stent thrombosis (ST), and stroke between prediabetes and diabetes in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD). A total of 4097 patients with STEMI and MVD (normoglycemia [group A 1001], prediabetes [group B 1518], and diabetes [group C 1578]) who received drug-eluting stents were evaluated. Patient-oriented composite outcomes were defi
Like
Comment
Share
